Pharmaceutical stocks are having a moment. The S&P 500 Pharmaceuticals Index recently rose 11% during five trading days, its ...

The global drug use disorder deaths have more than doubled since 1990, even as new addiction cases declined, highlighting a ...

Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, according to the latest edition of Trinity Life Sciences’ annual Drug Index—a ...

Amgen and Merck both climbed more than 5%, to push the Dow Jones Industrial Average up 0.1% to its second straight record. Thermo Fisher, Biogen and Eli Lilly were among the top gainers in the S&P 500 ...

Across the United States, rising temperatures due to climate change pose a growing threat to public health. Extreme heat ...